Alpa Laboratories Share Price Target 2025 to 2030: Hello Friends, today we are going to give you complete information about Alpa Laboratories Share Price. If you want to know what is the future of Alpa Laboratories Share Price and what is its target? So we will give you complete information about Alpa Laboratories Share in detail.
Alpa Laboratories Share Price Target
If we talk about Alpa Laboratories Share Price Target, then its share is going to increase in the coming 10 years. Talking about its performance, this stock has performed well in the last few months and has given money to all the investors. Investors of Alpa Laboratories Share are increasing very fast and all the investors are also investing funds. If you are a long-term investor then this share will give you good returns.
Alpa Laboratories Company Details
An Indian company called Alpa Laboratories Limited operates in the pharmaceutical and drug industry. The company produces completed dosage forms for pharmaceuticals. A wide range of generic and over-the-counter (OTC) medications in different completed dose forms for both human and veterinary usage are among its offerings. It provides capsules for human consumption, including cloxacillin capsules IP/BP, piroxicam capsules IP/BP, amoxycillin trihydrate capsules IP/BP, and ampicillin capsules IP/BP.
tablets like Albendazole Tablet IP/USP, Paracetamol Tablet IP/BP, and Tinidazole Tablets IP/BP, as well as Benzathine Penicillin Inj. IP/BP. Boluses like Alpamin Bolus and Alpazole Bolus, as well as injections like Atropine Inj. B.Vet.C. and others, are among its veterinary goods.
Fundamental Details
- P/E Ratio (TTM): 11.14
- EPS (TTM): 8.55
- Dividend Yield: 0.00%
- Market Cap: ₹200Cr
Financial Details
| 2019 | 2020 | 2021 | 2022 | 2023 | |
| Revenue | Rs. 83.29 Cr | Rs. 88.88 Cr | Rs. 102 Cr | Rs. 123 Cr | Rs. 102 Cr |
| Profit | Rs. 1.01 Cr | Rs. 1.85 Cr | Rs. 7.25 Cr | Rs. 14.09 Cr | Rs. 12.58 Cr |
| Net Worth | Rs. 98.49 Cr | Rs. 100 Cr | Rs. 108 Cr | Rs. 122 Cr | Rs. 135 Cr |
Alpa Laboratories Share Price Target 2025 to 2030
Alpa Laboratories Share Price Target 2025 ₹280.47, 2026 ₹395.56, 2027 ₹520.36, 2028 ₹638.74, 2029 ₹755.51, 2030 ₹895.78.
| Alpa Laboratories Share Price Target | Price |
| Alpa Laboratories Share Price Target 2025 | ₹280.47 |
| Alpa Laboratories Share Price Target 2026 | ₹395.56 |
| Alpa Laboratories Share Price Target 2027 | ₹520.36 |
| Alpa Laboratories Share Price Target 2028 | ₹638.74 |
| Alpa Laboratories Share Price Target 2029 | ₹755.51 |
| Alpa Laboratories Share Price Target 2030 | ₹895.78 |
Alpa Laboratories Share Price Target 2025
If we predict Alpa Laboratories Share for 2025, then looking at the growth of this share, the expectation is that this share will increase the money of all the investors and will give profit to all the investors. Looking at the market growth of this share, it is expected that this share will grow from Upto ₹280.47 by the end of 2025. Alpa Laboratories Share Price Target for 2025 is ₹280.47.
| Alpa Laboratories Share Price Target 2025 | ₹280.47 |
Alpa Laboratories Share Price Target 2030
Talking about Alpa Laboratories Share, this share is on a bullish trend every year and the year ending of this share is with profit only. If we talk about 2030, then it is expected that this share will close upto ₹895.78 this year. Looking at the bullish trend of this stock, it is expected that this year too it will add profit by making the money of all its investors profitable. Alpa Laboratories Share Price Target for 2030 is ₹895.78.
| Alpa Laboratories Share Price Target 2030 | ₹895.78 |
Also Read: Akzo Nobel India Share Price Target
Also Read: AksharChem (India) Share Price Target
Also Read: Akshar Spintex Share Price Target
Also Read: Aksh Optifibre Share Price Target
| Disclaimer: This article is for informational purposes only and should not be considered investment advice. The price targets or predictions provided are generated by a custom algorithm using deep learning, which may change due to market fluctuations, volume shifts, and market cycles. It is strongly recommended not to base investments solely on the target price mentioned. |